Culture filtrate proteins from BCG act as adjuvants for cytotoxic T lymphocyte induction

Culture filtrate proteins from BCG act as adjuvants for cytotoxic T lymphocyte induction

Mycobacterium bovis bacilli Calmette-Guerin (BCG) is a licensed vaccine against tuberculosis. It requires attenuated live bacteria to be effective, possibly because actively secreted proteins play a critical role in inducing anti-tuberculosis immunity. BCG also functions as an effective adjuvant. Mo...

Full description

Bibliographic Details
Main Authors:	Satoru Mizuno, Yasushi Chuma, Yukihiro Shibuya, Shigeo Horibata, Tomoe Baba, Emi Yokokawa, Kazuhiro Matsuo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Immunology
Subjects:	cytotoxic T lymphocytes culture filtrate protein tuberculosis Mycobacterium bovis bacilli Calmette-Guerin immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1271228/full

Similar Items

Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
by: Humberto Torloni, et al.
Published: (2023-08-01)

Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)

<italic>Mycobacterium</italic> bovis Associated Aneurysm of the Common Iliac Artery After Bacillus Calmette-Guérin Intravesical Treatment for Urothelial Carcinoma
by: Davide Voci, et al.
Published: (2022-12-01)

The safety of BCG revaccination in the context of COVID-19
by: Adriana Sánchez-García, et al.
Published: (2023-12-01)

Acute tenosynovitis following an accidental injection of Bacille Calmette-Guérin (BCG) in a health care worker: A case report
by: Mieko Tokano, et al.
Published: (2024-03-01)

Mesane içi BCG immünoterapisi: Travmatik kateterizasyon sonrası gelişen sepsis ve çoklu organ yetmezliği
by: Tufan ÇİÇEK, et al.
Published: (2014-07-01)

A case of post-BCG therapy renal granuloma concurrent with ureteral carcinoma
by: Tatsuya Otaki, et al.
Published: (2023-03-01)

Intravesical BCG immunotherapy: Sepsis and multiorgan failure developed after traumatic catheterization
by: Tufan Cicek, et al.
Published: (2014-02-01)

A new neonatal BCG vaccination pathway in England: a mixed methods evaluation of its implementation
by: Koren Jones, et al.
Published: (2024-04-01)

Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature
by: Oreoluwa Oladiran, et al.
Published: (2020-03-01)

Antibiotic therapy impact on intravesical BCG therapy efficacy for high-risk localized bladder cancer treatment
by: Cécile Aubert, et al.
Published: (2024-03-01)

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
by: Jinmiao Lu, et al.
Published: (2022-11-01)

HUBUNGAN RIWAYAT STATUS IMUNISASI BACILLE CALMETTE-GUÉRIN (BCG) DENGAN KEJADIAN TUBERKULOSIS (TB) PADA ANAK DI BADAN LAYANAN UMUM DAERAH RUMAH SAKIT UMUM CUT MEUTIA ACEH UTARA TAHUN 2015
by: Hedya Nadhrati Surura, et al.
Published: (2018-02-01)

Osteomielitis de tibia secundaria a la vacuna BCG en un paciente pediátrico inmunocompetente. Reporte de un caso
by: Javier Eugenio Dal Lago, et al.
Published: (2020-05-01)

Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana
by: Peter Yamoah, et al.
Published: (2023-01-01)

Pyoderma gangrenosum arising at the site of BCG immunization in a nine-month-old girl
by: Yuka Okura, et al.
Published: (2024-12-01)

Modeling vaccination and targeted removal of white‐tailed deer in Michigan for bovine tuberculosis control
by: Melinda K. Cosgrove, et al.
Published: (2012-12-01)

Future of TB Prevention: An Alternative To BCG
by: Sneka P, et al.
Published: (2022-10-01)

BCG and SARS-CoV-2—What Have We Learned?
by: Jakub Kulesza, et al.
Published: (2022-09-01)

Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions
by: Deepshikha Verma, et al.
Published: (2020-11-01)

Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette–Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases
by: Magdalena Jurczak, et al.
Published: (2025-02-01)

Harnessing <i>Mycobacterium bovis</i> BCG Trained Immunity to Control Human and Bovine Babesiosis
by: Reginaldo G. Bastos, et al.
Published: (2022-01-01)

Decoding the BCG and COVID-19 connection: an empirical analysis
by: Nand Lal Mishra, et al.
Published: (2024-05-01)

The influence of BCG on vaccine responses – a systematic review
by: Petra Zimmermann, et al.
Published: (2018-06-01)

Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trialResearch in context
by: Laure F. Pittet, et al.
Published: (2023-10-01)

A retrospective audit of neonatal BCG vaccination in Grampian, Scotland
by: Saba Savul, et al.
Published: (2023-12-01)

COVID-19 and Beyond: Exploring Public Health Benefits from Non-Specific Effects of BCG Vaccination
by: Kent J. Koster, et al.
Published: (2021-10-01)

Impact of Reducing Irritative Symptoms in Non-Muscle Invasive Bladder Cancer During BCG Instillation: A Pilot Study
by: Osman Köse, et al.
Published: (2020-12-01)

Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report
by: Pati Aji Achdiat, et al.
Published: (2023-01-01)

Transüretral Mesane Tümörü Rezeksiyonu Sonrası Bacillus Calmette-Guérin Bcg İmmünoterapisine Bağlı Nadir Bir Komplikasyon: Akut Solunum Yetmezliği ve Sepsis
by: Jale Bengi Çelik, et al.
Published: (2018-12-01)

The Brown Alga Padina australis Total Extract and Depressive-like Behavior Following BCG Inoculation in Mice
by: Afsaneh Yegdaneh, et al.
Published: (2023-03-01)

Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19
by: Jingli Du, et al.
Published: (2023-01-01)

BCG induced lower urinary tract symptoms during treatment for NMIBC—Mechanisms and management strategies
by: Georgia Bourlotos, et al.
Published: (2024-01-01)

Bacillus Calmette-Guérin pneumonitis after intravesical instillation: Report of two cases and a review of the literature
by: Martina Spisarova, et al.
Published: (2024-06-01)

Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal
by: Rasoul Hoseinpour, et al.
Published: (2024-02-01)

Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy
by: Wojciech Krajewski, et al.
Published: (2020-04-01)

BCG mediated protection of the lung against experimental SARS-CoV-2 infection
by: Kerry L. Hilligan, et al.
Published: (2023-09-01)

Report of 16 Years of the BCG Vaccine under the Expanded Program on Immunizations in Mexico (2006–2021)
by: Rodrigo Romero-Feregrino, et al.
Published: (2023-02-01)

Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease
by: Danielle Klinger, et al.
Published: (2021-05-01)

Previous BCG vaccination is associated with less severe clinical progression of COVID-19
by: Susan Martins Pereira, et al.
Published: (2023-04-01)